Predicate | Object |
---|---|
rdf:type | |
biopax3:comment |
FUNCTION: Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance, lamellipodial and filopodial dynamics, platelet activation and cell migration. VASP promotes actin filament elongation. It protects the barbed end of growing actin filaments against capping and increases the rate of actin polymerization in the presence of capping protein. VASP stimulates actin filament elongation by promoting the transfer of profilin- bound actin monomers onto the barbed end of growing actin filaments. Plays a role in actin-based mobility of Listeria monocytogenes in host cells. Regulates actin dynamics in platelets and plays an important role in regulating platelet aggregation. SUBUNIT: Homotetramer. Interacts with PFN1, PFN2, LPP, ACTN1 and ACTG1. Interacts, via the EVH1 domain, with the Pro-rich regions of ZYX. This interaction is important for targeting to focal adhesions and the formation of actin-rich structures at the apical surface of cells. Interacts, via the EVH1 domain, with the Pro- rich domain of Listeria monocytogenes actA. Interacts with APBB1IP. Interacts, via the Pro-rich domain, with the C-terminal SH3 domain of DNMBP (By similarity). SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton. Cell junction, focal adhesion. Cell projection, lamellipodium membrane. Cell projection, filopodium membrane. Note=Targeted to stress fibers and focal adhesions through interaction with a number of proteins including MRL family members. Localizes to the plasma membrane in protruding lamellipodia and filopodial tips. Stimulation by thrombin or PMA, also translocates VASP to focal adhesions. Localized along the sides of actin filaments throughout the peripheral cytoplasm under basal conditions. TISSUE SPECIFICITY: Highly expressed in platelets. DOMAIN: The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization. DOMAIN: The WH1 domain mediates interaction with XIRP1. PTM: Major substrate for cAMP-dependent (PKA) and cGMP-dependent protein kinase (PKG) in platelets. The preferred site for PKA is Ser-157, the preferred site for PKG/PRKG1, Ser-239. In ADP- activated platelets, phosphorylation by PKA or PKG on Ser-157 leads to fibrinogen receptor inhibition. Phosphorylation on Thr- 278 requires prior phosphorylation on Ser-157 and Ser-239. In response to phorbol ester (PMA) stimulation, phosphorylated by PKC/PRKCA. In response to thrombin, phosphorylated by both PKC and ROCK1. Phosphorylation at Thr-278 by AMPK does not require prior phosphorylation at Ser-157 or Ser-239. Phosphorylation modulates F-actin binding, actin filament elongation and platelet activation. Carbon monoxide (CO) promotes phosphorylation at Ser- 157, while nitric oxide (NO) promotes phosphorylation at Ser-157, but also at Ser-239. Response to NO and CO is blunted in platelets from diabetic patients, and VASP is not phosphorylated efficiently at Ser-157 and Ser-239. MISCELLANEOUS: VASP phosphorylation is used to monitor the effect of so-called antiplatelet drugs that reduce platelet reactivity and are used to prevent stent thrombosis, strokes and heart attacks in patients at risk for these problems. SIMILARITY: Belongs to the Ena/VASP family. SIMILARITY: Contains 1 WH1 domain. GENE SYNONYMS:VASP. COPYRIGHT: Protein annotation is derived from the UniProt Consortium (http://www.uniprot.org/). Distributed under the Creative Commons Attribution-NoDerivs License.,
SEQUENCE 380 AA; 39830 MW; 17634B8134DEBF59 CRC64;
|
biopax3:xref |
urn:biopax:RelationshipXref:HGNC_HGNC:12652,
urn:biopax:RelationshipXref:NCBI GENE_7408,
urn:biopax:RelationshipXref:REFSEQ_NP_003361,
urn:biopax:UnificationXref:UNIPROT_B2RBT9,
urn:biopax:UnificationXref:UNIPROT_P50552,
urn:biopax:UnificationXref:UNIPROT_Q6PIZ1,
urn:biopax:UnificationXref:UNIPROT_Q93035
|
biopax3:displayName |
VASP_HUMAN
|
biopax3:name |
VASP
|
biopax3:entityFeature |
urn:biopax:ModificationFeature:VASP_HUMAN_1,
urn:biopax:ModificationFeature:VASP_HUMAN_2,
urn:biopax:ModificationFeature:VASP_HUMAN_3,
urn:biopax:ModificationFeature:VASP_HUMAN_4,
urn:biopax:ModificationFeature:VASP_HUMAN_5,
urn:biopax:ModificationFeature:VASP_HUMAN_6,
urn:biopax:ModificationFeature:VASP_HUMAN_7,
urn:biopax:ModificationFeature:VASP_HUMAN_8,
urn:biopax:ModificationFeature:VASP_HUMAN_9
|
biopax3:organism | |
biopax3:sequence |
MSETVICSSRATVMLYDDGNKRWLPAGTGPQAFSRVQIYHNPTANSFRVVGRKMQPDQQVVINCAIVRGVKYNQATPNFHQWRDARQVWGLNFGSKEDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKRQQPGPSEHIERRVSNAGGPPAPPAGGPPPPPGPPPPPGPPPPPGLPPSGVPAAAHGAGGGPPPAPPLPAAQGPGGGGAGAPGLAAAIAGAKLRKVSKQEEASGGPTAPKAESGRSGGGGLMEEMNAMLARRRKATQVGEKTPKDESANQEEPEARVPAQSESVRRPWEKNSTTLPRMKSSSSVTTSETQPCTPSSSDYSDLQRVKQELLEEVKKELQKVKEEIIEAFVQELRKRGSP
|
biopax3:standardName |
Vasodilator-stimulated phosphoprotein
|